Status:
NOT_YET_RECRUITING
Fu's Subcutaneous Needling for Postacute Lateral Ankle Sprain and Prevention of Chronic Ankle Instability
Lead Sponsor:
Guangzhou University of Chinese Medicine
Conditions:
Chronic Ankle Instability
Lateral Ankle Sprain
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Introduction: Fu's Subcutaneous Needling (FSN) is a new type of acupuncture treatment method based on the subcutaneous tissue sweeping technique, and it has been proven to have a good therapeutic effe...
Eligibility Criteria
Inclusion
- Patients with first-time lateral ankle sprains
- The patient presents with symptoms of swelling and aching and weakness in the ankle joint. There may be a feeling of friction during joint movement, and the symptoms are aggravated after long - distance walking or on rainy and overcast days.
- The patient presents with swelling and tenderness in the anteroinferior aspect of the lateral malleolus and the anterolateral aspect of the medial malleolus, and has limited mobility during inversion and flexion-extension.
- Auxiliary examinations: No fracture or dislocation was found in the patient during the examination, and no fracture was detected by X-ray examination.
- The patient's sprain time is more than 3 weeks and within 6 months.
- Those who have not received surgical treatment at other medical institutions before coming to our hospital for treatment, can complete the treatment and accept follow - up.
- The patients' ages range from 18 to 60 years old.
- The patient voluntarily and is capable of signing the Informed Consent Form.
Exclusion
- Those with complete rupture of fractures or soft tissues such as muscles, tendons, and ligaments
- Patients with severe primary diseases such as heart, liver, kidney, hematopoietic system diseases and mental diseases
- Patients with tumors or tuberculosis in the ankle joint
- Patients with rheumatic and rheumatoid arthritis, or gout.
- Patients with acute inflammatory reactions such as redness, swelling, heat and pain and signs of infection in the ankle joint, or those accompanied by severe osteoarthritis.
- Patients with abnormal coagulation function or bleeding tendency, such as those with thrombocytopenia and severe diabetes.
- Patients during pregnancy and lactation
- Patients with damaged skin at the necessary needle insertion sites.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT07161427
Start Date
October 1 2025
End Date
September 1 2027
Last Update
September 16 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.